Lemaitre Vascular (LMAT) Change in Receivables (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Change in Receivables came in at $396000.0 in Q2 2026, down 41.76% year-over-year from $680000.0 in Q2 2025, and down 84.04% quarter-over-quarter from $2.5 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Change in Receivables (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Change in Receivables for 17 consecutive years, with $396000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Receivables fell 41.76% year-over-year to $396000.0 in Q2 2026; TTM through Jun 2026 was $525000.0, a 89.95% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 54.08% from the prior year.
- Change in Receivables was $396000.0 for Q2 2026 at Lemaitre Vascular, down from $2.5 million in the prior quarter.
- Over five years, Change in Receivables peaked at $5.8 million in Q1 2024 and troughed at -$3.9 million in Q3 2025.
- A 5-year average of $1.1 million and a median of $969500.0 in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables soared 357.0% in 2022 and slumped 513.59% in 2025, its largest moves.
- Over 5 years, Change in Receivables stood at $1.8 million in 2022, then tumbled by 41.09% to $1.1 million in 2023, then slumped by 196.12% to -$1.0 million in 2024, then surged by 251.82% to $1.5 million in 2025, then sank by 74.35% to $396000.0 in 2026.
- The last three Change in Receivables figures came in at $396000.0 (Q2 2026), $2.5 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 396,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 396,000.00 |
| Mar 31, 2026 | 2.48 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | -3.90 Mn |
| Jun 30, 2025 | 680,000.00 |
| Mar 31, 2025 | 4.62 Mn |
| Dec 31, 2024 | -1.02 Mn |
| Sep 30, 2024 | 942,000.00 |
| Jun 30, 2024 | 743,000.00 |
| Mar 31, 2024 | 5.75 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | -2.16 Mn |
| Jun 30, 2023 | 997,000.00 |
| Mar 31, 2023 | 3.24 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | -873,000.00 |
| Jun 30, 2022 | 659,000.00 |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 393,000.00 |
| Sep 30, 2021 | -1.06 Mn |